| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Finanšu pārskati |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2010-08-31 16:07:51 |
| Versijas komentārs | Noapaļots apgrozījuma rādītājs |
| Teksts |
Olaine, August 31, 2010
Semi-annual profit of Olainfarm more than
doubles
Profit of AS Olainfarm during the first six months of
this year has reached 1.79 million lats (2.55 million euro), while
the sales exceed 12.5 million lats (17.8 million euro). This
has been yet another best six months in Olainfarm’s history to a
large extent because of significant increase in exports: now the
company is exporting nearly 95% of its sales. In some smaller
markets the increase in sales exceeds 100%, e.g. in Kyrgyzstan
increase in Olainfarm sales has been more than 400% compared to six
months of 2009. Considerable increase took place also in
countries with bigger share in Olainfarm’s sales, like Kazakhstan,
where the sales grew by 75%, Belarus by 45%, Russia by 22%, Ukraine
by 14% compared to the same period last year.
“Olainfarm has reached yet another sales record and has
experienced its best second quarter so far. Main growth
drives still are new products, new markets and strengthened
marketing. We surely feel like we have caught the wave of stable
growth and we are efficiently riding it. We have all the
intentions to continue this way,” says Salvis Lapins, Member of the
Board of Olainfarm.
During the first six months of 2010 Olainfarm’s sales
grew by 17%, while the net profit by 117% compared to the first
half of 2009.
During the first six months of 2010, the sales to all
main markets of the Company have increased, except for Latvia and
Lithuania. Considerable increase in sales has been experienced
not only in countries with historically insignificant sales volumes
(Kyrgyzstan by more than 400%, Poland by more than 200%, Tajikistan
by 199%, Uzbekistan by 179%, Estonia by 144%), but also in
countries with much bigger share in Company’s sales, like
Kazakhstan by 75%, Belarus by 45%, Russia by 22%, Ukraine by
14%.
During the six months of 2010 several registration cases
have been finalized in Latvia, Lithuania, Estonia, Ukraine,
Kyrgyzstan and Albania. Also several registration files have been
submitted to other markets that are untypical for the company,
including Indonesia and Serbia. During the reporting period
pilot tests of R-Fenotropil have also been successfully completed
and the work has been launched to identify the optimal drug form
for this molecule.
In April 2010 Olainfarm has received a new Good
Manufacturing Practice compliance certificate.
Annual General Meeting of Shareholders of „Olainfarm”
held on April 29, 2010 approved the operating plan of the
company. According to it, the forecast sales of the Concern
for 2010 are 24.5 million lats (34.9 million Euro), but the net
profit is forecast at 2.7 million lats (3.8 million
Euro). Sales of the company during the 1st half of 2010 were
51% of target and net profit reached 67% of annual
target. Therefore the sales of the company develop according
to target results, while the net profit is slightly exceeding the
target for the year.
AS „Olainfarm“ is one of the largest companies in
Baltic countries with nearly 40 years of experience in production
of medicines and chemical and pharmaceutical products. The key
principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the
world. Currently products of “Olainfarm” are being exported to
more than 30 countries worldwide, including the Baltics, Russia,
other CIS, Europe, North America, Asia, and
Australia
Information prepared by
Salvis Lapins
JSC "Olainfarm"
Member of the Board
tel. +371 6 7013717,
Cell: + 371 2 6448873
Fax. + 371 6 7013777
E-mail:
slapinsh@olainfarm.lv
|
| Pielikumi |